InvestorsHub Logo

freethemice

03/27/12 11:57 PM

#77671 RE: entdoc #77670

Well said Entdoc. Everyone here knows this is a speculative biotech. It is risky and it can take a long time to pay off, if it ever does.
You are entirely correct, only invest what you can afford to lose. What is the use of continually complaining about it?
I invested in this because of the research, and because of it I keep looking for new ways this approach could be used.
I want to push it into new areas, like intracellular bacterial infections. What is wrong with that?
How better to gauge the true potential then by understanding the research and where it may lead?
FTM

geocappy1

03/28/12 2:55 AM

#77673 RE: entdoc #77670

Entdoc

Not writing the company off but getting closer to writing the investment off. All these potential new trials might be great but in too long and with too much money to throw more money at this company. For me to put any more money than I already have i will have to see something positive on the financial front. Enough with the endless science w/o any signs of financial success. They can't even muster a little rally.

realist1

03/28/12 2:10 PM

#77694 RE: entdoc #77670

RE "I'm a LONG way from writng this company off."

Carefully chosen words I'm sure.
You should differentiate between the company and the stock.
Yes, the company will probably continue for some time. Massive dilution and another likely reverse split will help with that.
But while the company may continue for some time, that does not mean the stock will recover its losses or even do well from this point. The head winds PPHM (the stock) face now are stronger than ever because their "currency" (shares) are worth so little. Because new shares must be issued to accomodate future cash burn because of their poor balance sheet, the dilution outlook is worse than ever.